By integrating computational docking, IF colocalization, Co-IP assays and functional studies, our study revealed that PAK2 directly interacts with E-cadherin and phosphorylates it at Ser840, thereby strengthening intercellular adhesion and promoting CTC cluster formation in breast cancer. Here, PAK2 is linked to breast cancer.